Skip to main content
ZEVRA THERAPEUTICS, INC. logo

ZEVRA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · ZVRA ISIN · US4884452065 LEI · 254900CU6T74V18Y1W18 US Manufacturing
Open in API
Filings indexed 830 across all filing types
Latest filing 2018-03-29 Earnings Release
Country US United States of America
Listing US ZVRA

About ZEVRA THERAPEUTICS, INC.

https://zevra.com/

Zevra Therapeutics, Inc. is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for patients with rare diseases. The company focuses on addressing significant unmet medical needs by combining a data-driven scientific approach with a patient-first perspective. Its portfolio includes commercial products such as MIPLYFFA®, an FDA-approved treatment for Niemann-Pick disease type C (NPC), and OLPRUVA®. Zevra Therapeutics also maintains a late-stage clinical pipeline, specializing in advancing promising medicines that face complex clinical and regulatory challenges for conditions with limited or no available treatments.

Recent filings

Filing Released Lang Actions
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated March 29, 2018, by KemPharm, Inc. It announces the release of the company's financial results for the quarter and year ended December 31, 2017, and references a press release and presentation attached as exhibits. The text explicitly states that the press release and presentation are furnished as exhibits and are not deemed filed for certain regulatory purposes. The document itself is short (3735 characters) and primarily serves as an announcement of the earnings release and related presentation, rather than containing the full financial results or detailed analysis. According to the classification rules, such a document announcing financial results and providing links or exhibits to the actual earnings release and presentation should be classified as an Earnings Release (ER) because it is the initial announcement of quarterly/periodical financial results with key highlights. The presence of a CFO signature and the nature of the content support this classification. Therefore, the filing type is ER with high confidence.
2018-03-29 English
FORM 4
Director's Dealing
2018-03-27 English
FORM 8-K
Investor Presentation Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated March 12, 2018. It announces that an investor presentation titled 'Management Presentation' dated March 2018 has been made available on the company's website and is filed as an exhibit. The text does not contain the presentation itself but refers to it and includes it as an exhibit. The document length is 3224 characters, which is relatively short and consistent with an announcement rather than a full report. According to the 'Menu vs Meal' rule, this is an announcement of a report (the investor presentation) rather than the report itself. Therefore, the correct classification is Investor Presentation (IP).
2018-03-12 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated February 23, 2018. It announces the FDA approval of a new drug application (NDA) for Apadaz and includes a press release and a presentation as exhibits. The content focuses on a regulatory disclosure event and a conference call presentation, not on detailed financial statements or comprehensive financial performance. The document length is 6574 characters, which is relatively short and primarily contains an announcement and related materials. There is no substantive financial data or detailed report content such as an annual or quarterly report. The document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit into more specific categories like earnings release or investor presentation, despite including a presentation as an exhibit. Therefore, the appropriate classification is Regulatory Filings (RNS).
2018-02-23 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-02-14 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-02-14 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.